The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer

por Constantin, Theodora A., Varela-Carver, Anabel, Greenland, Kyle K., de Almeida, Gilberto Serrano, Olden, Ellen, Penfold, Lucy, Ang, Simon, Ormrod, Alice, Leach, Damien A., Lai, Chun-Fui, Ainscow, Edward K., Bahl, Ash K., Carling, David, Fuchter, Matthew J., Ali, Simak, Bevan, Charlotte L.
Publicado 2023